Table 2.
5-HT1B receptor densities in three groups of rats: FSL, FRL and SPD. The values are given as means ±standard errors of the means in fmol/mg-tissue.
| REGIONS1 | FSL (N=5) | FRL (N=7) | SPD (N=7) |
|---|---|---|---|
| A | 63.4±5.3* | 26.5±4.5# | 43.5±4.5† |
| Acb | 129.3±7.6* | 60.7±6.4# | 87.5±6.4† |
| AOM | 45.3±7.3 | 26.1±6.2 | 30.4±6.2 |
| Cg | 45.7±5.4* | 21.3±4.6# | 38.4±4.6 |
| Ent | 53.9±5.3* | 21.7±4.5# | 40.1±4.5 |
| HiD | 35.7±3.2* | 11.3±2.7 | 19.8±2.7† |
| HiV | 59.0±4.3* | 24.9±3.7# | 52.8±3.7 |
| Hyp | 111.7±6.8* | 44.7±5.7# | 92.3±5.7† |
| CPuL | 104.0±4.3* | 41.6±3.6# | 80.2±3.6† |
| CPuM | 115.1±3.9* | 54.4±3.3# | 94.6±3.3† |
| DR | 126.8±4.6* | 49.0±3.9# | 113.9±3.9† |
| MR | 65.5±4.3* | 24.5±3.6# | 51.0±3.6† |
| Au | 37.5±3.9* | 17.5±3.3 | 27.7±3.3 |
| Fr | 40.0±6.4 | 20.5±5.4 | 31.3±5.4 |
| Pt | 26.6±2.3* | 11.5±2.0 | 15.1±2.0† |
| SM | 35.8±3.4* | 16.5±2.9# | 27.3±2.9 |
| V | 24.1±3.0* | 12.0±2.5 | 16.4±2.5 |
| GP | 274.6±13.2* | 127.±11.# | 237.±11. ( |
| VP | 403.(31.* | 199.(24.# | 349.(26. |
| IC | 40.7(3.5* | 10.7(3.0# | 22.9(3.0( |
| SC | 148.9(2.9* | 61.7(2.5# | 137.5(2.5.( |
| LC | 148.0±8.8* | 46.3±7.5# | 110.8±7.5† |
| LG | 69.1±3.0* | 22.2±2.6# | 52.5±2.6† |
| Sd | 380.7±23.8* | 179.±20.# | 326.±20. |
| SepN | 140.4±6.1* | 57.5±5.1# | 119.5±5.1† |
| SN | 537.±47.* | 298.±39. | 376.±39.† |
| Tha | 24.1±2.6* | 9.4±2.2 | 15.0±2.2† |
1
Abbreviations are listed at the beginning.
*
Difference is significant when 5-HT1B receptor densities between the FSL and FRL rats were compared; p<0.05 with post-hoc Newman-Keuls correction
#
Difference is significant when 5-HT1B receptor densities between the FRL and SPD rats were compared; p<0.05 with post-hoc Newman-Keuls correction
†
Difference is significant when 5-HT1B receptor densities between the FSL and SPD rats were compared; p<0.05 with post-hoc Newman-Keuls correction